Drug
Insulin Lispro clinical trials
Also written Humalog, LY900014, LY275585 and Lispro.
- studies test it
- 130
- open now
- 4
- in phase 3
- 24
- first study started
- 2002
Keep track of what changes. Save the Insulin Lispro studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Other names
Combined with it in one product
Studies by the year they started
128 studies that test it; most in 2017 (13)
| Year | Studies |
|---|---|
| 2002 | 2 |
| 2004 | 2 |
| 2006 | 4 |
| 2007 | 9 |
| 2008 | 7 |
| 2009 | 5 |
| 2010 | 6 |
| 2011 | 6 |
| 2012 | 3 |
| 2013 | 7 |
| 2014 | 7 |
| 2015 | 10 |
| 2016 | 9 |
| 2017 | 13 |
| 2018 | 10 |
| 2019 | 12 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 5 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 51
- Phase 2
- 13
- Phase 3
- 24
- Phase 4
- 28
- No phase
- 17
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 100 · Other 30
Eli Lilly and Company (67) · Halozyme Therapeutics (7) · Adocia (7) · Medical University of Warsaw (4) · Biodel (4) · Wockhardt (4) · Sansum Diabetes Research Institute (2) · Joslin Diabetes Center (2)
Often tested with
Tested in the same studies.
Insulin Aspart (14) · Insulin glulisine (8) · Insulin Glargine (7) · Insulin, Regular, Human (7) · Insulin (5) · Hyaluronidase (human recombinant) (4) · Insulin, Regular (3) · Insulin degludec (2)
Studies
Open first, then newest update. How each study uses Insulin Lispro is read from its arms, and is right about nine times in ten.
Testing it · 130
- Perioperative Glucose Monitoring and Treatment to Reduce Risk of Surgical Site Infections and ComplicationsEnrolling by invitationNot applicableSt. Peter's Hospital, Albany, NYNCT06765655Written as Insulin Lispro Injection
- Mealtime or Post-meal Dosing of URLi in Medtronic 780G Hybrid Closed Loop SystemNot yet recruitingPhase 4Tel-Aviv Sourasky Medical CenterNCT06600776Written as Ultra Rapid Lispro (URLi)
- A Trial of Three- and Seven-days Insulin Infusions SetRecruitingNot applicableSteno Diabetes Center CopenhagenNCT06532461Written as Humalog
- Automated Fully Closed-Loop Insulin Delivery in Type 1 Diabetes With Ultra-Rapid Lispro (ACOLYTE Study)RecruitingNot applicableManchester University NHS Foundation TrustNCT05660941Written as Lispro
- A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)CompletedPhase 1Eli Lilly and CompanyNCT06280703Written as Insulin Lispro
- A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in IndiaCompletedPhase 4Eli Lilly and CompanyNCT06370715Written as Insulin Lispro-aabc
- Is Brain Insulin Resistance a Feature of the Biology of Depression in AdolescentsCompletedNot applicableCentre for Addiction and Mental HealthNCT05571878Written as Humalog
- Ultrarapid Insulin Administered by a Bihormonal Closed Loop System in Patients With Type 1 DiabetesCompletedNot applicableInreda Diabetic B.V.NCT05508061Written as Insulin Lispro Cartridge [Lyumjev]
- The Impact of Two Different Insulin Dose Calculation on Postprandial Glycemia After Mixed Meal.CompletedPhase 4Medical University of WarsawNCT04124302Written as Insulin Lispro
- A Study of LY8888AX in Participants Using a Connected Insulin Management PlatformCompletedNot applicableEli Lilly and CompanyNCT05893797Written as Insulin Lispro
- A Study of Lispro Formulations in Healthy ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT02293551Written as Lispro
- Dynamics of Insulin Absorption in Subclinical Lipohypertrophy Using the Euglycemic Clamp TechniqueWithdrawnNot applicableGraydon MeneillyNCT03229850Written as Insulin lispro
- A Study of LY900014 (Lyumjev) Versus Insulin Lispro (Humalog) in Participants With Type 1 DiabetesCompletedPhase 1Eli Lilly and CompanyNCT05262387Written as Lyumjev with 50% basal rate reduction
- Super-Bolus: Effects on Postprandial Glycemia After High Glycemic Index MealCompletedPhase 4Medical University of WarsawNCT04019821Written as Insulin Lispro
- A Study of Mealtime Insulin LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring (PRONTO-Time in Range)CompletedPhase 3Eli Lilly and CompanyNCT04605991Written as LY900014
- A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 DiabetesCompletedPhase 3Eli Lilly and CompanyNCT03952130Written as LY900014
- Individualizing Automated Closed Loop Glucose Control Through Pharmacokinetic Profiling in an Insulin-Only Bionic PancreasTerminatedPhase 2/3Massachusetts General HospitalNCT03262116Written as Humalog
- Humalog® Mix50/50(tm) as a Treatment for Gestational DiabetesCompletedPhase 4Sansum Diabetes Research InstituteNCT01613807Written as Insulin LISPRO
- A Study of LY900014 and Insulin Degludec in Participants With Type 1 DiabetesCompletedPhase 2Eli Lilly and CompanyNCT04585776Written as LY900014
- Effect of Splitting Mealtime Insulin Doses After Mixed Meals High in Fat and ProteinCompletedPhase 4Sohag UniversityNCT04783376Written as : Insulin, lispro and regular insulin
See all 130 studies that test Insulin Lispro →
Given in every arm · 31 — Insulin Lispro is usual care beside what is tested
- A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 DiabetesRecruitingPhase 1Eli Lilly and CompanyNCT06945406Written as Lispro SC
- Do Antipsychotics Block Insulin Action in the Brain: is it a Class Effect?RecruitingPhase 4Centre for Addiction and Mental HealthNCT07109245Written as Insulin Lispro
- A Fully Automated Lyumjev and Pramlintide Delivery System for Adults With Type 1 DiabetesRecruitingPhase 2/3McGill University Health Centre/Research Institute of the McGill University Health CentreNCT06046417Written as Lyumjev
- Oral Anti Diabetic Agents in the HospitalTerminatedPhase 4Emory UniversityNCT04416269Written as Supplemental insulin
- A Study of Insulin Efsitora Alfa (LY3209590) as a Weekly Basal Insulin Compared to Insulin Glargine in Adult Participants With Type 2 Diabetes on Multiple Daily InjectionsCompletedPhase 3Eli Lilly and CompanyNCT05462756Written as Insulin Lispro (U100)
- SITAgliptin Plus GLARgine to Glycemic Control in the Hospital Setting (SITAGLAR-H)CompletedPhase 4Hospital de Especialidades, Centro Medico Nacional "La Raza", Instituto Mexicano del Seguro SocialNCT05579119Written as Lispro
- A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Type 1 Diabetes MellitusCompletedPhase 3Eli Lilly and CompanyNCT03338023Written as Insulin Lispro
- Feasibility Trial Testing the Bionic Pancreas With ZP4207CompletedPhase 2Zealand PharmaNCT02971228Written as Insulin Lispro
- Sitagliptin for Hyperglycemia in Patients With T2DM Undergoing Cardiac SurgeryCompletedPhase 4Emory UniversityNCT02556918Written as Supplemental insulin (Insulin lispro)
- Single Ascending Dose Study of MK-1092 in Healthy Participants and in Participants With Type 1 and Type 2 Diabetes Mellitus (MK-1092-001)CompletedPhase 1Merck Sharp & Dohme LLCNCT03170544Written as Lispro 1.2 nmol/kg
- A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)CompletedPhase 3Eli Lilly and CompanyNCT01621178Written as Insulin lispro
- A Study to Compare and Measure the Effects of Insulin Peglispro (LY2605541) and Glargine on Meal Time Insulin RequirementsCompletedPhase 1Eli Lilly and CompanyNCT02152384Written as Insulin Lispro
- Randomized, Double Blind, 2 Way Crossover Study of CSII With, Versus Without, Pretreatment With Human HyaluronidaseCompletedPhase 4Halozyme TherapeuticsNCT01526733Written as Insulin lispro
- Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes MellitusCompletedPhase 2Halozyme TherapeuticsNCT01194245Written as Insulin lispro
- Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 DiabetesWithdrawnPhase 4University of Texas Southwestern Medical CenterNCT00505882Written as Lispro
- CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM)CompletedPhase 4Halozyme TherapeuticsNCT01848990Written as Insulin lispro
- A Study To Compare the Effects of Insulin Peglispro and Glargine on Insulin Sensitivity and Meal Time Insulin Requirements in Type 2 DiabeticsCompletedPhase 1Eli Lilly and CompanyNCT02197520Written as Insulin Lispro
- Sitagliptin in Non-Diabetic Patients Undergoing General SurgeryCompletedPhase 4Emory UniversityNCT02741687Written as Supplemental insulin (insulin lispro)
- A Study of LY2605541 in Participants With Type 1 Diabetes MellitusCompletedPhase 3Eli Lilly and CompanyNCT01792284Written as Insulin Lispro
- A Study in Participants With Type I Diabetes MellitusCompletedPhase 3Eli Lilly and CompanyNCT01454284Written as Insulin Lispro
Showing 20 of 31.
As the comparator · 48 — what is tested is compared with Insulin Lispro
- Single vs Multi-Dose Insulin for Glycemic Control (SUGAR)RecruitingNot applicableRutgers, The State University of New JerseyNCT07171684Written as Insulin glargine + insulin lispro
- Premixed Glucagon/Insulin Solution for Faster Insulin Absorption in Type 1 DiabetesTerminatedPhase 1/2St. Olavs HospitalNCT06854861Written as Lyumjev 100 UNT/ML Injectable Solution
- Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin DegludecCompletedPhase 2Diasome PharmaceuticalsNCT06238778Written as Lispro
- Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 2 DiabetesCompletedPhase 3Tonghua Dongbao Pharmaceutical Co.,LtdNCT05834868Written as Insulin Lispro Injection
- Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 1 DiabetesCompletedPhase 3Tonghua Dongbao Pharmaceutical Co.,LtdNCT07282054Written as Insulin Lispro
- Simplified Insulin Regimen for the ElderlyTerminatedPhase 4University of MiamiNCT03660553Written as Insulin Lispro
- A Trial to Evaluate the Pharmacokinetics and Pharmacodynamics of THDB0206 Injection in Healthy Chinese SubjectsCompletedPhase 1Tonghua Dongbao Pharmaceutical Co.,LtdNCT06153329Written as Humalog®
- A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without MetforminCompletedPhase 3Eli Lilly and CompanyNCT04537923Written as Insulin Lispro (U100)
- A Trial to Assess the Efficacy and Safety of M1 Pram P037 Prandial Insulin in Subjects With Type 1 Diabetes (T1DM)CompletedPhase 2AdociaNCT04816890Written as Insulin lispro
- Insulin Schemes for Type 2 Diabetes ControlCompletedPhase 4Universidad de GuanajuatoNCT03350984Written as Glargine and Lispro insulin
- Metformin and Sitagliptin Therapy for Adult Patients With Type 2 Diabetes Admitted to the General Medical UnitWithdrawnPhase 4Rush University Medical CenterNCT02250794Written as insulin glargine and insulin lispro
- A Study of LY900027 Given by Insulin Pump to Participants With Type 1 Diabetes MellitusCompletedPhase 1Eli Lilly and CompanyNCT04161976Written as Insulin Lispro
- Effect of Exenatide on 24h-UAER in Patients With Diabetic NephropathyCompletedPhase 4Nanfang Hospital, Southern Medical UniversityNCT02690883Written as Lispro
- Gan & Lee Evaluation of New Biosimilar for Type 1 LisproWithdrawnPhase 3Gan and Lee Pharmaceuticals, USANCT04254380Written as Humalog
- Dose Response of Dance 501 in Subjects With Type 2 Diabetes MellitusCompletedPhase 2Dance Biopharm Inc.NCT04100473Written as Insulin Lispro (Humalog U-100)
- PK and PD Profile of Dance 501 in Healthy, Non-diabetic Subjects With Mild to Moderate Asthma or COPDTerminatedPhase 2Dance Biopharm Inc.NCT03307512Written as Insulin Lispro (Humalog U-100)
- A Trial to Assess a Co-formulation of an Insulin Analog and Pramlintide in Subjects With Type 1 Diabetes MellitusCompletedPhase 1AdociaNCT03916640Written as Humalog®
- A Trial to Investigate Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BioChaperone® Pramlintide Insulin in Patients With Type 1 Diabetes MellitusCompletedPhase 1AdociaNCT03512236Written as Humalog®
- Dipeptidyl Peptidase-4 Inhibitor (Sitagliptin) Therapy in the Inpatients With Type 2 DiabetesCompletedPhase 4Emory UniversityNCT01378117Written as lispro
- Comparison of Hepatic Directed Vesicle (HDV)-Insulin Lispro Versus Insulin Lispro to Further Improve Glycemic ControlCompletedPhase 2Diasome PharmaceuticalsNCT03096392Written as Insulin Lispro 100 UNT/ML
Showing 20 of 48.
Codes
What other systems call Insulin Lispro · ClinicalTrials.gg INT008949
- MeSH (NLM) D061268Insulin LisproConfirmed ClinicalTrials.gov, Wikidata
- UNII (FDA) GFX7QIS1IIINSULIN LISPROConfirmed FDA, Wikidata
- RxNorm 86009Confirmed FDA, Wikidata
- Wikidata Q3492616Insulin LisproConfirmed FDA, Wikidata
- NCI Thesaurus C29123Insulin LisproConfirmed FDA, Wikidata
- DrugBank DB00046One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D061268 | Insulin Lispro | Confirmed ClinicalTrials.gov, Wikidata |
| UNII (FDA) | GFX7QIS1II | INSULIN LISPRO | Confirmed FDA, Wikidata |
| RxNorm | 86009 | — | Confirmed FDA, Wikidata |
| Wikidata | Q3492616 | Insulin Lispro | Confirmed FDA, Wikidata |
| NCI Thesaurus | C29123 | Insulin Lispro | Confirmed FDA, Wikidata |
| DrugBank | DB00046 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.